Nicholson C. David 4
4 · Allergan plc · Filed Jan 3, 2019
Insider Transaction Report
Form 4
Allergan plcAGN
Nicholson C. David
Chief R&D Officer
Transactions
- Tax Payment
Ordinary Shares, par value $0.0001
2018-12-31$133.66/sh−1,150$153,709→ 16,207 total
Footnotes (1)
- [F1]Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.